ArticleFrontiers in medicine2026
Development and validation of a machine learning model for predicting preoperative deep vein thrombosis in elderly hip fracture patients.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Web-Based Machine Learning Calculator for Predicting Preoperative Deep Vein Thrombosis in Elderly Hip Fractures Patients.Clinical interventions in aging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hip fractures in older adults pose a global health challenge. Deep vein thrombosis (DVT) is common, increasing surgical risk, delaying procedures, and causing severe thromboembolic events. It hampers recovery and lowers the quality of life. Prompt risk assessment and intervention are crucial. This study aims to develop and validate a machine learning model to predict DVT before surgery in elderly hip fracture patients, aiming to improve preoperative assessments and streamline clinical care pathways. Materials and methods: This study employed a retrospective design and included elderly patients who were hospitalized for hip fractures at a university-affiliated hospital between July 2022 and May 2025. A total of 782 patients met the inclusion criteria. The dataset was randomly divided into a training set (70%) and a validation set (30%). Five supervised machine learning algorithms were used to develop predictive models: decision tree (DT), extreme gradient boosting (XGBoost), support vector machine (SVM), light gradient boosting machine (LightGBM), and logistic regression (LR). Model performance was evaluated on the basis of discrimination, calibration, and clinical applicability, with SHAP analysis used for interpretability. Results: Among the 782 elderly patients with hip fractures, 186 (23.8%) DVT. Five features were selected for model construction: injury-to-admission time, D-dimer levels, hemoglobin levels, albumin levels, and activated partial thromboplastin time (APTT). Among all models, XGBoost achieved superior predictive accuracy, yielding an area under the receiver operating characteristic curve (AUC) of 0.829 (95% CI: 0.788-0.870) on the training set and 0.808 (95% CI: 0.742-0.874) on the validation set. Calibration curve assessment validated the model's strong agreement between predicted and observed outcomes, and decision curve analysis (DCA) demonstrated notable clinical advantages. Conclusion: The XGBoost-based predictive model for preoperative DVT in elderly patients with hip fractures demonstrated superior performance. By integrating the SHAP method to enhance model interpretability and developing an intuitive web-based tool, the model's clinical applicability was markedly improved. This predictive tool holds promise for assisting clinicians in risk assessment and guiding medical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.